Bryant v. Astrazeneca LP

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Claire C. Cecchi · 12,702 cases in index

Docket number

2:22-cv-07001

Cause

28:1332 Diversity-Product Liability
28 U.S.C. § 1332 — Diversity jurisdiction

Nature of suit

367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Injury from a drug, medical device, or health-care product — often grouped into mass-tort litigation.

Jurisdiction

Diversity

Jury demand

Plaintiff

Date filed

12/05/2022

Date terminated

01/25/2023

51,438 Product Liability cases in this court are indexed here.

Parties

• plaintiff · Bryant · 3690 cases
• defendant · Astrazeneca LP Pharmaceuticals & Biotechnology · 10349 cases

Part of a Larger Litigation Pattern

This is one of 10,350 Product Liability cases in our index naming ASTRAZENECA LP — a possible mass-tort or coordinated-litigation cluster.

• Smith v. Astrazeneca LP
  District Court, D. New JerseyFiled 07/12/2023
• Haithcock v. Astrazeneca LP
  District Court, D. New JerseyFiled 02/24/2023
• Herndon v. Astrazeneca LP
  District Court, D. New JerseyFiled 02/23/2023
• Dean v. Astrazeneca LP
  District Court, D. New JerseyFiled 02/23/2023
• Johnston v. Astrazeneca LP
  District Court, D. New JerseyFiled 02/18/2023
• Love v. Astrazeneca LP
  District Court, D. New JerseyFiled 02/14/2023

About Product Liability Lawsuits

Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

Frequently Asked Questions

What is Bryant v. Astrazeneca LP?

Bryant v. Astrazeneca LP is a federal product liability lawsuit filed on 12/05/2022 in the District Court, D. New Jersey. The case was terminated on 01/25/2023. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

What type of case is this?

It is classified as “Product Liability” under the federal nature-of-suit system. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:22-cv-07001.

When was the case filed?

Bryant v. Astrazeneca LP was filed on 12/05/2022. It was terminated on 01/25/2023.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 1332 — Diversity jurisdiction.